Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2024-07-22 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Newspaper publication - AGM notice
Regulatory Filings
2024-07-22 English
Business Responsibility and Sustainability Report FY 2023-24
Environmental & Social Information Classification · 95% confidence The document is titled 'Business Responsibility and Sustainability Report (BRSR)' for the financial year 2023-24 and is described as forming part of the Annual Report 2023-24. It contains detailed disclosures on environmental, social, governance, and sustainability practices, including employee data, business activities, risk management related to sustainability, and compliance with national guidelines. The content focuses on ESG factors and responsible business conduct rather than financial statements or earnings. The document is lengthy (15,000 characters) and contains substantive report content, not just an announcement or certification. Therefore, it fits the category of Environmental & Social Information (SR) rather than Annual Report (10-K) or Regulatory Filings (RNS).
2024-07-20 English
Newspaper publication - AGM notice
Regulatory Filings
2024-07-20 English
Notice of 72nd Annual General Meeting
AGM Information Classification · 95% confidence The document is a Notice of the 72nd Annual General Meeting (AGM) of Fermenta Biotech Limited scheduled for August 12, 2024. It includes details about the agenda items such as adoption of audited financial statements for the year ended March 31, 2024, declaration of dividend, appointment of director, approval of continuation of a non-executive director, remuneration of cost auditor, and approval of material related party transactions. The document is addressed to the stock exchange and mentions that the Notice has been sent to members and is available on the company's website. The document is a formal notice announcing the AGM and its agenda, not the actual Annual Report or financial statements themselves. It is also quite detailed and exceeds 5,000 characters, but it is clearly a Notice of AGM rather than the report or presentation materials shared during the AGM. Therefore, the appropriate classification is AGM Information (AGM-R).
2024-07-20 English
Annual Report 2023-24
Annual Report Classification · 100% confidence The document is a detailed Annual Report for the financial year 2023-24 of Fermenta Biotech Limited. It includes a cover letter referencing Regulation 34(1) of SEBI Listing Regulations about submission of the Annual Report and Notice of the 72nd AGM. The text contains extensive corporate overview, management discussion, financial statements, board of directors information, and other statutory reports. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The document explicitly states it is the Annual Report for 2023-24 and includes financial performance, management reviews, and statutory reports. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2024-07-20 English
Certificate under regulation 74(5) of SEBI (DP) Regulations
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2024. It confirms the dematerialization of securities and related compliance matters. The document is a formal certification letter from the company secretary and the registrar and transfer agent, confirming compliance with regulatory requirements. It does not contain financial statements, management discussion, or detailed financial data. It is primarily a regulatory compliance certificate rather than a financial report or announcement of voting results, capital changes, or management changes. Given the nature of the document as a regulatory compliance certificate, it fits best under Regulatory Filings (RNS). The document length is 3621 characters, which is short and consistent with a certification letter rather than a full report.
2024-07-19 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.